Jihua Han

1.6k total citations
20 papers, 925 citations indexed

About

Jihua Han is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Jihua Han has authored 20 papers receiving a total of 925 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Cancer Research and 5 papers in Surgery. Recurrent topics in Jihua Han's work include RNA modifications and cancer (5 papers), MicroRNA in disease regulation (4 papers) and Cancer-related molecular mechanisms research (4 papers). Jihua Han is often cited by papers focused on RNA modifications and cancer (5 papers), MicroRNA in disease regulation (4 papers) and Cancer-related molecular mechanisms research (4 papers). Jihua Han collaborates with scholars based in China and United States. Jihua Han's co-authors include Shangha Pan, Yaliang Lan, Ruipeng Song, Jiabei Wang, Lianxin Liu, Fanzheng Meng, Tongsen Zheng, Wen Bi, Jiewu Zhang and Rui Pang and has published in prestigious journals such as Journal of Hepatology, Molecular Cancer and European Journal of Pharmacology.

In The Last Decade

Jihua Han

18 papers receiving 915 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jihua Han China 13 659 554 101 82 78 20 925
Shengnan Ren China 14 554 0.8× 405 0.7× 129 1.3× 53 0.6× 72 0.9× 40 809
Tianli Fan China 14 609 0.9× 391 0.7× 167 1.7× 65 0.8× 92 1.2× 29 832
Jing Ding China 15 588 0.9× 337 0.6× 105 1.0× 43 0.5× 72 0.9× 37 844
Xiaohua Zhang China 15 508 0.8× 401 0.7× 139 1.4× 44 0.5× 74 0.9× 34 732
Xiefu Zhang China 21 661 1.0× 501 0.9× 161 1.6× 84 1.0× 105 1.3× 42 971
Zhigang Sun China 18 556 0.8× 323 0.6× 122 1.2× 39 0.5× 76 1.0× 49 842
Jar‐Yi Ho Taiwan 19 605 0.9× 333 0.6× 150 1.5× 60 0.7× 114 1.5× 32 892
Vijesh Kumar Yadav Taiwan 18 502 0.8× 310 0.6× 173 1.7× 62 0.8× 147 1.9× 41 814
Jue Yang China 18 557 0.8× 269 0.5× 203 2.0× 96 1.2× 97 1.2× 60 933

Countries citing papers authored by Jihua Han

Since Specialization
Citations

This map shows the geographic impact of Jihua Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jihua Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jihua Han more than expected).

Fields of papers citing papers by Jihua Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jihua Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jihua Han. The network helps show where Jihua Han may publish in the future.

Co-authorship network of co-authors of Jihua Han

This figure shows the co-authorship network connecting the top 25 collaborators of Jihua Han. A scholar is included among the top collaborators of Jihua Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jihua Han. Jihua Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Jihua, et al.. (2025). Erianin induces apoptosis of thyroid cancer cells via TNF signaling pathway. European Journal of Pharmacology. 1006. 178167–178167.
2.
Zhang, Liang, Zhaoming Ding, Jihua Han, et al.. (2024). Recurrence and postoperative quality of life after surgical resection of unilateral cT1–T3N1bM0 papillary thyroid carcinoma. Gland Surgery. 13(10). 1740–1751. 2 indexed citations
3.
Ding, Zhaoming, Liang Zhang, Jihua Han, et al.. (2023). Utility of video-assisted method for identifying and preserving the external branch of the superior laryngeal nerve during thyroidectomy. Frontiers in Surgery. 10. 1118083–1118083.
4.
Zhang, Liang, Zhaoming Ding, Jihua Han, Wen Bi, & Chunlei Nie. (2023). Optimal range of lymph node dissection in patients with unilateral papillary thyroid carcinoma with lateral cervical lymph node metastasis. Frontiers in Oncology. 13. 1307937–1307937. 2 indexed citations
5.
Han, Jihua, Changming Xie, Bo Liu, et al.. (2023). Tetraspanin 1 regulates papillary thyroid tumor growth and metastasis through c‐Myc‐mediated glycolysis. Cancer Science. 114(12). 4535–4547. 6 indexed citations
6.
He, Guoqing, Rui Pang, Jihua Han, et al.. (2021). TINCR inhibits the proliferation and invasion of laryngeal squamous cell carcinoma by regulating miR-210/BTG2. BMC Cancer. 21(1). 753–753. 11 indexed citations
7.
Song, Yang, Weiwei An, Hongmei Wang, et al.. (2021). LRH1 Acts as an Oncogenic Driver in Human Osteosarcoma and Pan-Cancer. Frontiers in Cell and Developmental Biology. 9. 643522–643522. 7 indexed citations
8.
Nie, Chunlei, Jihua Han, Wen Bi, et al.. (2021). Circular RNA circ_0000644 promotes papillary thyroid cancer progression via sponging miR-1205 and regulating E2F3 expression. Cell Cycle. 21(2). 126–139. 12 indexed citations
9.
Liang, Yingjian, Dandan Zhang, Tongsen Zheng, et al.. (2020). lncRNA-SOX2OT promotes hepatocellular carcinoma invasion and metastasis through miR-122-5p-mediated activation of PKM2. Oncogenesis. 9(5). 54–54. 47 indexed citations
10.
Cui, Yifeng, Shuhang Liang, Shugeng Zhang, et al.. (2020). ABCA8 is regulated by miR-374b-5p and inhibits proliferation and metastasis of hepatocellular carcinoma through the ERK/ZEB1 pathway. Journal of Experimental & Clinical Cancer Research. 39(1). 90–90. 32 indexed citations
11.
Pei, Tiemin, Fanzheng Meng, Peng Xiao, et al.. (2019). MUC13 promotes intrahepatic cholangiocarcinoma progression via EGFR/PI3K/AKT pathways. Journal of Hepatology. 72(4). 761–773. 73 indexed citations
12.
Cui, Yifeng, Dan Sun, Ruipeng Song, et al.. (2019). Upregulation of cystatin SN promotes hepatocellular carcinoma progression and predicts a poor prognosis. Journal of Cellular Physiology. 234(12). 22623–22634. 21 indexed citations
13.
Li, Dan, Chaoqun Wang, Wenjing Jiang, et al.. (2018). PGC1α promotes cholangiocarcinoma metastasis by upregulating PDHA1 and MPC1 expression to reverse the Warburg effect. Cell Death and Disease. 9(5). 466–466. 60 indexed citations
14.
Liu, Xirui, Yingjian Liang, Ruipeng Song, et al.. (2018). Long non-coding RNA NEAT1-modulated abnormal lipolysis via ATGL drives hepatocellular carcinoma proliferation. Molecular Cancer. 17(1). 90–90. 212 indexed citations
15.
Bi, Wen, Jiayu Huang, Chunlei Nie, et al.. (2018). CircRNA circRNA_102171 promotes papillary thyroid cancer progression through modulating CTNNBIP1-dependent activation of β-catenin pathway. Journal of Experimental & Clinical Cancer Research. 37(1). 275–275. 180 indexed citations
16.
Lan, Yaliang, Jihua Han, Yan Wang, et al.. (2018). STK17B promotes carcinogenesis and metastasis via AKT/GSK-3β/Snail signaling in hepatocellular carcinoma. Cell Death and Disease. 9(2). 236–236. 45 indexed citations
17.
Yang, Guangchao, Yingjian Liang, Tongsen Zheng, et al.. (2016). FCN2 inhibits epithelial–mesenchymal transition-induced metastasis of hepatocellular carcinoma via TGF-β/Smad signaling. Cancer Letters. 378(2). 80–86. 69 indexed citations
18.
Li, Keyu, Jiabei Wang, Jihua Han, et al.. (2016). Overexpression of ZNF703 facilitates tumorigenesis and predicts unfavorable prognosis in patients with cholangiocarcinoma. Oncotarget. 7(46). 76108–76117. 12 indexed citations
19.
Pei, Tiemin, Qinghui Meng, Jihua Han, et al.. (2016). (−)-Oleocanthal inhibits growth and metastasis by blocking activation of STAT3 in human hepatocellular carcinoma. Oncotarget. 7(28). 43475–43491. 65 indexed citations
20.
Sun, Haijun, Xianzhi Meng, Jihua Han, et al.. (2013). Anti-cancer activity of DHA on gastric cancer—an in vitro and in vivo study. Tumor Biology. 34(6). 3791–3800. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026